Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the DNA Diagnostics Market Growth Performance Trended Historically, And What Lies Ahead?

The dimension of the DNA diagnostics market has been expanding briskly over the previous years. There is predicted growth from $23.1 billion in 2024 to $25.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The increase seen in the past years can be credited to the escalating demand for personalized medication, the growing acceptance of genetic testing in correlation with molecular diagnostics in clinical practice, the rise in biomedical research, the growing incidence of cancer patients, and increased utilization of diagnostic tests.

What Is the Forecast for the DNA Diagnostics Market Size Through 2029?

The market size for DNA diagnostics is predicted to experience substantial growth in the upcoming years, reaching $38.64 billion in 2029 with a compound annual growth rate (CAGR) of 10.8%. The expansion during this forecast period can be ascribed to factors such as the rise in cancer prevalence, the escalating demand for definitive diagnostic tests, increasing instances of genetic disorders, heightened emphasis on biomarker identification, the growing phenomenon of rare diseases and orphan drugs, along with the evolution of telemedicine and remote testing. Noteworthy trends to look forward to in this projection period include the incorporation of microbiome analysis, the utilization of blockchain technology, amalgamation of various omic data, non-invasive testing methods, multiplex integration of omics, the innovation of portable and accessible DNA diagnostic tools, and the progress of next-generation sequencing (NGS).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15356&type=smp

What are the Key Market Players in DNA Diagnostics Market and How They’re Evolving?

Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

What Are the Primary Growth Drivers in the DNA Diagnostics Market?

Increasing occurrence of genetic illnesses is projected to accelerate the advancement of the DNA diagnostics market in the future. Genetic maladies are health issues resulting from one or more irregularities in the genome. The surge in genetic disorders cases can be attributed to improved diagnostic skills, broadened genetic testing, environmental factors, and inbreeding in populations, leading to a heightened awareness and detection of genetic disorders. DNA diagnostics allow for the accurate identification of genetic disorders by analyzing genetic material, thus enabling early detection, bespoke treatments, and informed family planning decisions. For example, in February 2023, the World Health Organization (WHO), a United Nations agency based in Switzerland that focuses on global public health, estimated that 240,000 global infant deaths occurred within 28 days of birth each year due to congenital illnesses. Additionally, congenital diseases resulted in the death of 170,000 children between 1 month and 5 years of age. As such, the growing incidence of genetic disorders is propelling the expansion of the DNA diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15356&type=smp

What Are the Leading Segments in the Global DNA Diagnostics Industry?

The DNA diagnostics market covered in this report is segmented –

1) By Product Type: Instruments, Reagents, Software And Services

2) By Technology: Polymerase Chain Reaction, Microarray, In-situ Hybridization, Sequencing Technology, Mass Spectrometry

3) By Application: Oncology, Infectious Diseases Treatment, Myogenic Disorder Treatment, Clinical Diagnostic Confirmation, Prenatal, Pre-Implantation, Other Applications

4) By End User: Point Of Care, Diagnostic Centers, Self-Testing Or Over-The-Counter (OTC)

Subsegments

1) By Instruments: DNA Analyzers, PCR Machines (Polymerase Chain Reaction), Sequencers (Next-Generation Sequencing, Sanger Sequencing), Electrophoresis Systems, Gene Expression Analyzers, Microarray Systems, Flow Cytometers, Spectrophotometers

2) By Reagents: PCR Reagents, DNA Extraction Kits, Sequencing Reagents, Antibodies For DNADetection, Fluorescent Dyes And Probes, Chemicals For Nucleic Acid Purification, Buffer Solutions For DNA Analysis, Hybridization And Amplification Kits

3) By Software: DNA Data Analysis Software, Bioinformatics Platforms, Genomics Software For Sequencing Data, Laboratory Information Management Systems (LIMS), Data Visualization Tools, Genetic Variant Analysis Software, Genome Mapping Software

4) By Services: Genetic Testing Services, DNA Sequencing Services, Bioinformatics Consulting And Analysis, Clinical Diagnostic Services, Genetic Counseling Services, Custom DNA Diagnostics Services, Research And Development Services

What Are the Key Market Trends in the DNA Diagnostics Industry?

Leading firms in the DNA diagnostics sector are concentrating on the development of ground-breaking products like liquid biopsy tests, aimed at early cancer detection. Liquid biopsy is a low-invasive medical procedure that identifies and studies biomarkers such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes that tumors or other cells release into the bloodstream. For instance, Laboratory Corporation, a diagnostics company in the U.S healthcare sector, introduced a novel liquid biopsy test, LabCorp Plasma Focus, in May 2023. This test uses genetic sequencing to examine the circulating cell-free DNA (cfDNA) discharged by tumor cells which enables oncologists to customize and enhance patient care through targeted therapy schemes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

What Is the Regional Outlook for the DNA Diagnostics Market?

North America was the largest region in the DNA diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15356

This Report Delivers Insight On:

1. How big is the dna diagnostics market, and how is it changing globally?

2. Who are the major companies in the dna diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the dna diagnostics market right now?

4. Which products or customer segments are growing the most in the dna diagnostics market?

5. What factors are helping or slowing down the growth of the dna diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model